Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Neurometabolic Disorders market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neurometabolic Disordersmarket, defines the market attractiveness level of Neurometabolic Disorders market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neurometabolic Disorders industry, describes the types of Neurometabolic Disorders market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neurometabolic Disorders market and the development prospects and opportunities of Neurometabolic Disorders industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neurometabolic Disorders market in Chapter 13.
By Player:
Greenovation Biotech
ExSAR Corporation
Protalix
Neuraltus Pharmaceuticals
Amicus
Lixte Biotechnology
Biomarin
Dong-A Socio Group
JCR Pharmaceuticals
Pharming Group
ISU Abxis
Protalix BioTherapeutics
Biosidus
Shire
Amicus Therapeutics
Shire BioTherapeutics
UAB Proforma
Genzyme
By Type:
Gaucher’s Disease
Fabry Disease
Pompe Disease
Mucopolysaccharidosis VI
Other
By End-User:
Oral
Parenteral
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neurometabolic Disorders Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neurometabolic Disorders Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neurometabolic Disorders Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neurometabolic Disorders Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neurometabolic Disorders Market Analysis and Outlook to 2022
-
7.1 Global Neurometabolic Disorders Consumption (2017-2022)
-
7.2 United States Neurometabolic Disorders Consumption (2017-2022)
-
7.3 Europe Neurometabolic Disorders Consumption (2017-2022)
-
7.4 China Neurometabolic Disorders Consumption (2017-2022)
-
7.5 Japan Neurometabolic Disorders Consumption (2017-2022)
-
7.6 India Neurometabolic Disorders Consumption (2017-2022)
-
7.7 South Korea Neurometabolic Disorders Consumption (2017-2022)
8 Region and Country-wise Neurometabolic Disorders Market Analysis and Outlook to 2028
-
8.1 Global Neurometabolic Disorders Consumption Forecast (2022-2028)
-
8.2 United States Neurometabolic Disorders Consumption Forecast (2022-2028)
-
8.3 Europe Neurometabolic Disorders Consumption Forecast (2022-2028)
-
8.4 China Neurometabolic Disorders Consumption Forecast (2022-2028)
-
8.5 Japan Neurometabolic Disorders Consumption Forecast (2022-2028)
-
8.6 India Neurometabolic Disorders Consumption Forecast (2022-2028)
-
8.7 South Korea Neurometabolic Disorders Consumption Forecast (2022-2028)
9 Global Neurometabolic Disorders Market Outlook by Types and Applications to 2022
-
9.1 Global Neurometabolic Disorders Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Gaucher’s Disease Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Fabry Disease Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Pompe Disease Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Mucopolysaccharidosis VI Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Neurometabolic Disorders Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Parenteral Consumption and Growth Rate (2017-2022)
10 Global Neurometabolic Disorders Market Outlook by Types and Applications to 2028
-
10.1 Global Neurometabolic Disorders Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Gaucher’s Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Fabry Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Pompe Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Mucopolysaccharidosis VI Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neurometabolic Disorders Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Parenteral Consumption Forecast and Growth Rate (2022-2028)
11 Global Neurometabolic Disorders Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neurometabolic Disorders Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neurometabolic Disorders Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neurometabolic Disorders Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neurometabolic Disorders Market Competitive Analysis
-
14.1 Greenovation Biotech
-
14.1.1 Greenovation Biotech Company Details
-
14.1.2 Greenovation Biotech Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Greenovation Biotech Neurometabolic Disorders Product and Service
-
14.2 ExSAR Corporation
-
14.2.1 ExSAR Corporation Company Details
-
14.2.2 ExSAR Corporation Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 ExSAR Corporation Neurometabolic Disorders Product and Service
-
14.3 Protalix
-
14.3.1 Protalix Company Details
-
14.3.2 Protalix Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Protalix Neurometabolic Disorders Product and Service
-
14.4 Neuraltus Pharmaceuticals
-
14.4.1 Neuraltus Pharmaceuticals Company Details
-
14.4.2 Neuraltus Pharmaceuticals Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Neuraltus Pharmaceuticals Neurometabolic Disorders Product and Service
-
14.5 Amicus
-
14.5.1 Amicus Company Details
-
14.5.2 Amicus Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Amicus Neurometabolic Disorders Product and Service
-
14.6 Lixte Biotechnology
-
14.6.1 Lixte Biotechnology Company Details
-
14.6.2 Lixte Biotechnology Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Lixte Biotechnology Neurometabolic Disorders Product and Service
-
14.7 Biomarin
-
14.7.1 Biomarin Company Details
-
14.7.2 Biomarin Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Biomarin Neurometabolic Disorders Product and Service
-
14.8 Dong-A Socio Group
-
14.8.1 Dong-A Socio Group Company Details
-
14.8.2 Dong-A Socio Group Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Dong-A Socio Group Neurometabolic Disorders Product and Service
-
14.9 JCR Pharmaceuticals
-
14.9.1 JCR Pharmaceuticals Company Details
-
14.9.2 JCR Pharmaceuticals Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 JCR Pharmaceuticals Neurometabolic Disorders Product and Service
-
14.10 Pharming Group
-
14.10.1 Pharming Group Company Details
-
14.10.2 Pharming Group Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Pharming Group Neurometabolic Disorders Product and Service
-
14.11 ISU Abxis
-
14.11.1 ISU Abxis Company Details
-
14.11.2 ISU Abxis Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 ISU Abxis Neurometabolic Disorders Product and Service
-
14.12 Protalix BioTherapeutics
-
14.12.1 Protalix BioTherapeutics Company Details
-
14.12.2 Protalix BioTherapeutics Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Protalix BioTherapeutics Neurometabolic Disorders Product and Service
-
14.13 Biosidus
-
14.13.1 Biosidus Company Details
-
14.13.2 Biosidus Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Biosidus Neurometabolic Disorders Product and Service
-
14.14 Shire
-
14.14.1 Shire Company Details
-
14.14.2 Shire Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Shire Neurometabolic Disorders Product and Service
-
14.15 Amicus Therapeutics
-
14.15.1 Amicus Therapeutics Company Details
-
14.15.2 Amicus Therapeutics Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Amicus Therapeutics Neurometabolic Disorders Product and Service
-
14.16 Shire BioTherapeutics
-
14.16.1 Shire BioTherapeutics Company Details
-
14.16.2 Shire BioTherapeutics Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Shire BioTherapeutics Neurometabolic Disorders Product and Service
-
14.17 UAB Proforma
-
14.17.1 UAB Proforma Company Details
-
14.17.2 UAB Proforma Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 UAB Proforma Neurometabolic Disorders Product and Service
-
14.18 Genzyme
-
14.18.1 Genzyme Company Details
-
14.18.2 Genzyme Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.18.3 Genzyme Neurometabolic Disorders Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neurometabolic Disorders
-
Figure Neurometabolic Disorders Picture
-
Table Global Neurometabolic Disorders Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neurometabolic Disorders Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neurometabolic Disorders Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neurometabolic Disorders Consumption by Country (2017-2022)
-
Figure United States Neurometabolic Disorders Consumption and Growth Rate (2017-2022)
-
Table Europe Neurometabolic Disorders Consumption and Growth Rate (2017-2022)
-
Figure China Neurometabolic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Japan Neurometabolic Disorders Consumption and Growth Rate (2017-2022)
-
Figure India Neurometabolic Disorders Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neurometabolic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Neurometabolic Disorders Consumption Forecast by Country (2022-2028)
-
Figure United States Neurometabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neurometabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neurometabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neurometabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neurometabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neurometabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gaucher’s Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Fabry Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Pompe Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Mucopolysaccharidosis VI Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Parenteral Consumption and Growth Rate (2017-2022)
-
Figure Global Gaucher’s Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fabry Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pompe Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mucopolysaccharidosis VI Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Parenteral Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neurometabolic Disorders Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neurometabolic Disorders Export by Region (Top 5 Countries) (2017-2028)
-
Table Greenovation Biotech (Foundation Year, Company Profile and etc.)
-
Table Greenovation Biotech Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Greenovation Biotech Neurometabolic Disorders Product and Service
-
Table ExSAR Corporation (Foundation Year, Company Profile and etc.)
-
Table ExSAR Corporation Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table ExSAR Corporation Neurometabolic Disorders Product and Service
-
Table Protalix (Foundation Year, Company Profile and etc.)
-
Table Protalix Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Protalix Neurometabolic Disorders Product and Service
-
Table Neuraltus Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Neuraltus Pharmaceuticals Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neuraltus Pharmaceuticals Neurometabolic Disorders Product and Service
-
Table Amicus (Foundation Year, Company Profile and etc.)
-
Table Amicus Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amicus Neurometabolic Disorders Product and Service
-
Table Lixte Biotechnology (Foundation Year, Company Profile and etc.)
-
Table Lixte Biotechnology Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lixte Biotechnology Neurometabolic Disorders Product and Service
-
Table Biomarin (Foundation Year, Company Profile and etc.)
-
Table Biomarin Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biomarin Neurometabolic Disorders Product and Service
-
Table Dong-A Socio Group (Foundation Year, Company Profile and etc.)
-
Table Dong-A Socio Group Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dong-A Socio Group Neurometabolic Disorders Product and Service
-
Table JCR Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table JCR Pharmaceuticals Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table JCR Pharmaceuticals Neurometabolic Disorders Product and Service
-
Table Pharming Group (Foundation Year, Company Profile and etc.)
-
Table Pharming Group Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharming Group Neurometabolic Disorders Product and Service
-
Table ISU Abxis (Foundation Year, Company Profile and etc.)
-
Table ISU Abxis Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table ISU Abxis Neurometabolic Disorders Product and Service
-
Table Protalix BioTherapeutics (Foundation Year, Company Profile and etc.)
-
Table Protalix BioTherapeutics Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Protalix BioTherapeutics Neurometabolic Disorders Product and Service
-
Table Biosidus (Foundation Year, Company Profile and etc.)
-
Table Biosidus Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biosidus Neurometabolic Disorders Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Neurometabolic Disorders Product and Service
-
Table Amicus Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Amicus Therapeutics Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amicus Therapeutics Neurometabolic Disorders Product and Service
-
Table Shire BioTherapeutics (Foundation Year, Company Profile and etc.)
-
Table Shire BioTherapeutics Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire BioTherapeutics Neurometabolic Disorders Product and Service
-
Table UAB Proforma (Foundation Year, Company Profile and etc.)
-
Table UAB Proforma Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table UAB Proforma Neurometabolic Disorders Product and Service
-
Table Genzyme (Foundation Year, Company Profile and etc.)
-
Table Genzyme Neurometabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genzyme Neurometabolic Disorders Product and Service
-
